Subrata Panda &Amp; Sohini Das

Stories by Subrata Panda &Amp; Sohini Das

Now, RuPay cards will work offline too!

Now, RuPay cards will work offline too!

Rediff.com   19 Dec 2020

RuPay National Common Mobility Card's offline wallet can be used to make ticket payments in transit, including in metros, cabs, etc, enabling automatic, quick, cashless payments.

Bad loans set to rise in 2nd half of FY21: Axis

Bad loans set to rise in 2nd half of FY21: Axis

Rediff.com   18 Dec 2020

While the stress is lower than projections, it would be higher than what we saw last year because of the pandemic: Axis.

Vaccine will be available to all

Vaccine will be available to all

Rediff.com   17 Dec 2020

The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.

 Covaxin shows robust response

Covaxin shows robust response

Rediff.com   17 Dec 2020

Bharat Biotech is in the middle of conducting a phase 3 trial with 22,000 subjects.

COVID-19 vaccines likely to have longer shelf life

COVID-19 vaccines likely to have longer shelf life

Rediff.com   14 Dec 2020

A longer shelf life is critical, given many makers have started manufacturing vaccines and stockpiling them, so as to make them available in the market immediately after approval, reports Sohini Das.

Insurers face Covid claims of Rs 10,000 cr so far

Insurers face Covid claims of Rs 10,000 cr so far

Rediff.com   12 Dec 2020

According to the data compiled by General Insurance Council, which is not publicly available, the insurers have settled 508,334 claims amounting to over Rs 4,800 crore.

Is this Indian Covid vaccine better than Pfizer's?

Is this Indian Covid vaccine better than Pfizer's?

Rediff.com   12 Dec 2020

India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.

Covishield volunteer decides to move court against Serum Institute

Covishield volunteer decides to move court against Serum Institute

Rediff.com   11 Dec 2020

'Our client is suffering due to the ill-effects of the vaccine. He has to be compensated for his suffering. Further, a detailed investigation has to be done on the Covishield vaccine and its side-effects,' says the volunteer's advocate.

Why Modi visited Serum's Covid vaccine unit

Why Modi visited Serum's Covid vaccine unit

Rediff.com   10 Dec 2020

The PM's visit would signal a strong intent towards making sure India becomes a beneficiary as vaccines become a massively traded commodity in the coming years.

Serum Institute set to sign deal with Centre for Covishield

Serum Institute set to sign deal with Centre for Covishield

Rediff.com   9 Dec 2020

By January-February, it's expected to have at least 100 million doses for the Indian government, reports Sohini Das.

LIC has invested Rs 55,000 cr in equity market

LIC has invested Rs 55,000 cr in equity market

Rediff.com   9 Dec 2020

'In FY21, as of October, LIC has booked a profit of Rs 18,800 crore through sale of equities.'

How Indian pharma bounced back from lockdown lows

How Indian pharma bounced back from lockdown lows

Rediff.com   7 Dec 2020

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.

Covid: How Pfizer plans to resolve cold storage issues in India

Covid: How Pfizer plans to resolve cold storage issues in India

Rediff.com   7 Dec 2020

The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring. Sohini Das and Ruchika Chitravanshi report.

LIC's equity portfolio value crosses $86 billion

LIC's equity portfolio value crosses $86 billion

Rediff.com   4 Dec 2020

Assuming that the value of LIC's holding has risen in line with the markets, its portfolio size today could be around $86 billion, higher than the previous record of $84 billion in March 2018.

How states are preparing for Covid vaccine distribution

How states are preparing for Covid vaccine distribution

Rediff.com   2 Dec 2020

Each state has its own weak areas that need attention. Some states have already identified the gaps and sought the Centre's help. Vinay Umarji, Ishita Ayan Dutt, Samreen Ahmad and Sohini Das report.

India may get first Covid-19 vaccine by February

India may get first Covid-19 vaccine by February

Rediff.com   30 Nov 2020

The government plans to immunise 30 million people in the first phase, starting February, and by July, the target is to vaccinate 250 million people, reports Sohini Das.

Indian Immunologicals to set up new vaccine plant, raise capacity by 35%

Indian Immunologicals to set up new vaccine plant, raise capacity by 35%

Rediff.com   26 Nov 2020

The company has a pipeline of viral vaccines including Zika, dengue, varicella, as well as a potential Covid-19 inoculation.

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Serum Institute to keep 200 mn doses of Covid vaccine ready by Jan

Rediff.com   13 Nov 2020

'SII has started stockpiling the vaccine and now has roughly 40 million doses ready. It is using some of the capacities it had for under development products for the COVID-19 vaccine and by January we will have a capacity to make 100 million doses per month and a stockpile of 200 million doses.'

RBI allows all NBFCs to co-lend with banks

RBI allows all NBFCs to co-lend with banks

Rediff.com   6 Nov 2020

Under the co-lending model, banks have to take their share of the individual loans on a back-to-back basis on their books while NBFCs are required to retain a minimum of 20 per cent share of the individual loans on their books.

Covid insurance claims reach a whopping 475,000

Covid insurance claims reach a whopping 475,000

Rediff.com   4 Nov 2020

To add to the worry of the insurers, non-Covid claims, which were muted in the initial months of the pandemic, have also picked up pace and are more or less at pre-Covid levels.